Aurinia Pharmaceuticals Ownership | Who Owns Aurinia Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Aurinia Pharmaceuticals Ownership Summary


Aurinia Pharmaceuticals is owned by 41.90% institutional investors, 7.15% insiders, and 50.95% retail investors. Tang capital management is the largest institutional shareholder, holding 7.22% of AUPH shares. iShares Russell 2000 ETF is the top mutual fund, with 2.14% of its assets in Aurinia Pharmaceuticals shares.

AUPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAurinia Pharmaceuticals41.90%7.15%50.95%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tang capital management10.03M7.22%$84.95M
Blackrock9.27M6.44%$52.94M
Blackrock funding, inc. /de7.69M5.54%$65.16M
Nea management company3.97M2.86%$33.62M
State street2.92M2.04%$26.20M
Geode capital management1.76M1.23%$15.84M
Goldman sachs group1.75M1.22%$15.73M
Vanguard group1.73M1.21%$15.53M
Armistice capital1.63M1.17%$13.80M
Nuveen asset management1.49M1.04%$13.40M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management10.03M4.29%$84.95M
Nea management company3.97M2.53%$33.62M
Hussman strategic advisors357.00K0.69%$3.02M
Ironwood investment management115.86K0.48%$981.38K
Entrypoint capital101.20K0.43%$857.18K
Rice hall james & associates550.50K0.25%$4.66M
Armistice capital1.63M0.24%$13.80M
City center advisors26.16K0.24%$221.53K
Virtus fund advisers7.03K0.20%$63.15K
Readystate asset management lp657.84K0.17%$5.57M

Top Buyers

HolderShares% AssetsChange
Readystate asset management lp657.84K0.17%657.84K
Blackrock9.27M0.00%609.18K
Jpmorgan chase927.30K0.00%424.48K
Qube research1.24M0.01%386.36K
Woodline partners lp849.48K0.05%348.98K

Top Sellers

HolderShares% AssetsChange
Armistice capital1.63M0.24%-3.37M
Rock springs capital management lp---1.18M
Blackrock funding, inc. /de7.69M0.00%-1.07M
Point72 asset management---849.62K
Goldman sachs group1.75M0.00%-655.85K

New Positions

HolderShares% AssetsChangeValue
Readystate asset management lp657.84K0.17%657.84K$5.57M
Squarepoint ops116.60K0.00%116.60K$1.05M
Norges bank114.05K0.00%114.05K$651.20K
Marshall wace, llp108.06K0.00%108.06K$915.27K
Vestcor89.82K0.02%89.82K$761.00K

Sold Out

HolderChange
Vima-25.00
Nelson, van denburg & campbell wealth management group-26.00
Federation des caisses desjardins du quebec-40.00
Parallel advisors-43.00
Stephens consulting-45.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20252271.79%58,203,989-6.12%412.10%99-1.98%646.67%
Mar 31, 20253-98.60%312,556-99.46%-0.01%1-99.00%--100.00%
Dec 31, 20242106.60%57,561,302-0.09%402.48%9816.67%4911.36%
Sep 30, 20241957.73%57,393,9453.76%402.69%83-2.35%43-
Jun 30, 2024180-8.63%55,314,7510.64%382.61%8513.33%42-32.26%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Russell 2000 ETF2.81M2.14%-53.45K
Fidelity Small Cap Index1.18M0.90%-178.29K
iShares Russell 2000 Growth ETF1.04M0.79%-
State St Russell Sm/Mid Cp® Indx SL Cl I833.00K0.63%-
State St Russell Sm/Mid Cp® Indx NL Cl C820.80K0.60%-
iShares Biotechnology ETF742.01K0.56%6.34K
Lazard US Sm Cap Eq WW Dist EUR577.32K0.43%58.09K
Vanguard Russell 2000 ETF555.52K0.42%-44.21K
International Biotechnology Ord534.69K0.41%-
Vanguard Explorer Inv425.41K0.31%134.96K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 05, 2025TANG KEVIN-Buy$2.34M
Aug 01, 2025TANG KEVIN-Buy$10.12M
Aug 04, 2025TANG KEVIN-Buy$1.13M
Aug 01, 2025Keenan Greg Chief Medical OfficerSell$210.00K
Mar 07, 2025Keenan Greg Chief Medical OfficerSell$68.35K

Insider Transactions Trends


DateBuySell
2025 Q331
2025 Q2--
2025 Q1610
2024 Q432
2024 Q3-1

AUPH Ownership FAQ


Who Owns Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals shareholders are primarily institutional investors at 41.90%, followed by 7.15% insiders and 50.95% retail investors. The average institutional ownership in Aurinia Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which Aurinia Pharmaceuticals falls below.

Who owns the most shares of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals’s largest shareholders are Tang capital management (10.03M shares, 7.22%), Blackrock (9.27M shares, 6.44%), and Blackrock funding, inc. /de (7.69M shares, 5.54%). Together, they hold 19.20% of Aurinia Pharmaceuticals’s total shares outstanding.

Does Blackrock own Aurinia Pharmaceuticals?

Yes, BlackRock owns 6.44% of Aurinia Pharmaceuticals, totaling 9.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 52.94M$. In the last quarter, BlackRock increased its holdings by 609.18K shares, a 7.03% change.

Who is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tang capital management is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.29% of its assets in 10.03M Aurinia Pharmaceuticals shares, valued at 84.95M$.

Who is the top mutual fund holder of Aurinia Pharmaceuticals shares?

iShares Russell 2000 ETF is the top mutual fund holder of Aurinia Pharmaceuticals shares, with 2.14% of its total shares outstanding invested in 2.81M Aurinia Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools